Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c
November 2, 2023 4:35 PM EDTVir Biotechnology Inc. (NASDAQ: VIR) reported Q3 EPS of ($1.22), $0.01 worse than the analyst estimate of ($1.21). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.71 million.
For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.
... More